Phlo Corporation Reverse Stock Split Process Completed

JACKSONVILLE, Fla., March 19 /PRNewswire-FirstCall/ -- Phlo Corporation (the "Company") announced today the completion of its 100-for-1 reverse stock split process. According to Nasdaq, the reverse split will be reflected in the quotation of the price of the Company's common stock in the public market beginning today.

Shareholders will receive instructions shortly for surrendering their certificates to the transfer agent in exchange for new certificates reflecting the reverse split.

Additionally, as of today, the trading symbol for Phlo's common stock is "PHCP.PK".

Phlo is a biotechnology company and a manufacturer and marketer of products (primarily liquids) containing patented and patent-pending biotechnologies. Phlo is focusing its technology generation and acquisition efforts on those technologies related to enhancing cognition and personal performance, reducing the effects of aging, and preventing or ameliorating cancer.

Certain statements made herein that are not historical constitute "forward-looking" statements within the meaning of the Private Litigation Reform Act of 1995 and may contain words such as "anticipate," "believe," "expect," "future," "may," "will," "should," "plan," "projected," "intend," and similar expressions to identify such forward-looking statements. Such statements are based on a number of assumptions and on information and estimates supplied to Phlo Corporation by sources currently available to it. Such assumptions and estimates are subject to uncertainties, contingencies, and other factors, many of which are beyond Phlo Corporation's control. Actual results may differ materially from the statements set forth above.

CONTACT: James B. Hovis of Phlo Corporation, +1-904-505-3834